I agree that this site is using cookies. You can find further informations here.
X
Castrillo-Viguera, Carmen
66  results:
Search for persons X
?
1

Genome-Wide Association Studies of ARIA From the Aducanumab..:

Loomis, Stephanie J. ; Miller, Ryan ; Castrillo-Viguera, Carmen...
Neurology.  102 (2024)  3 - p. , 2024
Link: https://doi.org/10.1212/..
 
?
2

Item-Level Analysis of Clinical Measures in Patients With E..:

Cohen, Sharon ; He, Ping ; Benea, Mihaela Levitchi...
Neurology.  98 (2022)  18_supplement - p. , 2022
Link: https://doi.org/10.1212/..
 
?
3

Alzheimer disease neuropathology in a patient previously tr..:

Plowey, Edward D. ; Bussiere, Thierry ; Rajagovindan, Raj...
Acta Neuropathologica.  144 (2022)  1 - p. 143-153 , 2022
Link: https://doi.org/10.1007/..
 
?
4

Subgroup Analyses of the Amyloid PET Substudies From EMERGE..:

Chen, Tianle ; Rajagovindan, Rajasimhan ; Wu, Hao...
Neurology.  98 (2022)  18_supplement - p. , 2022
Link: https://doi.org/10.1212/..
 
?
5

Reductions in Biomarkers of Alzheimer's Disease Pathophysio..:

Chen, Tianle ; Rajagovindan, Rajasimhan ; Nisenbaum, Laura...
Neurology.  98 (2022)  18_supplement - p. , 2022
Link: https://doi.org/10.1212/..
 
?
6

Considerations for the Real-World Management of ARIA From t..:

Hughes, Richard ; Burkett, Patrick ; Chalkias, Spyridon...
Neurology.  98 (2022)  18_supplement - p. , 2022
Link: https://doi.org/10.1212/..
 
?
7

Development of a cognitive composite for measuring change i..:

Jaeger, Judith ; Yang, Lili ; Li, Yumeng...
Parkinsonism & Related Disorders.  92 (2021)  - p. 94-100 , 2021
Link: https://doi.org/10.1016/..
 
?
8

Matching comparisons of therapeutic efficacy suggest better..:

Scott, Thomas F. ; Su, Ray ; Xiong, Kuangnan...
Therapeutic Advances in Neurological Disorders.  14 (2021)  - p. 175628642097591 , 2021
Link: https://doi.org/10.1177/..
 
?
9

EMBARK: A Phase 3b, Open-Label, Single-Arm, Safety Study to..:

Castrillo-Viguera, Carmen ; Chalkias, Spyros ; Burkett, Patrick...
Neurology.  96 (2021)  15_supplement - p. , 2021
Link: https://doi.org/10.1212/..
 
?
10

Matching-adjusted comparisons demonstrate better clinical o..:

Newsome, Scott D. ; Mokliatchouk, Oksana ; Castrillo-Viguera, Carmen.
Multiple Sclerosis and Related Disorders.  40 (2020)  - p. 101954 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Peginterferon beta-1a every 2 weeks demonstrated better cli..:

Scott, Thomas ; Mokliatchouk, Oksana ; Castrillo-Viguera, Carmen..
Revue Neurologique.  175 (2019)  - p. S96 , 2019
Link: https://doi.org/10.1016/..
 
?
12

Peginterferon beta-1a every 2 weeks demonstrated better out..:

Scott, Thomas ; Mokliatchouk, Oksana ; Castrillo-Viguera, Carmen..
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
?
13

Interim Analyses of Fixed-Dose and Titration Cohorts from P..:

Castrillo-Viguera, Carmen ; Haeberlein, Samantha Budd ; Von Rosenstiel, Philipp...
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
?
14

Overall Response Score: A Novel Disability Endpoint That Al..:

Chang, Ih ; Kappos, Ludwig ; Giovannoni, Gavin...
Neurology.  90 (2018)  15_supplement - p. , 2018
Link: https://doi.org/10.1212/..
 
?
15

Addressing the targeting range of the ABILHAND-56 in relaps..:

Cleanthous, Sophie ; Strzok, Sara ; Pompilus, Farrah...
Multiple Sclerosis Journal - Experimental, Translational and Clinical.  4 (2018)  2 - p. 205521731877699 , 2018
Link: https://doi.org/10.1177/..
 
1-15